Mo said:Oh shut up already didn't you have enough of making yourself look stupid? This isn't your field, move on already.
The Marketing Authorisation for 'Faslodex' in Europe was based on data from two pivotal phase III trials,1,2 which compared the efficacy and tolerability of 'Faslodex' to that of 'Arimidex' (anastrozole) in the treatment of hormone sensitive advanced breast cancer in postmenopausal women who had previously been treated with prior endocrine therapy.
And what does this have to do with Arimidex itself?...-it's not the same drug, period. The comparison you are talking about is for post-menopausal women only, but the drugs themselves are different.
But yes, anti-doping methods of bb champions is not my field. So what medicine was used every three days to prevent detection -and by who and when?
-boy, if those are experiments or not.
Anyway, Faslodex's life is only 1 year around (only in hospitals, no prescription for pharmacy yet)- the other for some months in US...I had the impression you were talking of older times, as I doupt attempts like this can get to be known around in such a short time.
So what's the deal with you?